Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 1
1978 1
1979 2
1980 4
1981 3
1982 3
1983 4
1984 6
1985 5
1986 4
1987 3
1988 4
1989 5
1990 4
1991 8
1992 10
1993 9
1994 15
1995 24
1996 14
1997 14
1998 22
1999 19
2000 14
2001 13
2002 22
2003 19
2004 27
2005 37
2006 38
2007 33
2008 33
2009 41
2010 39
2011 42
2012 65
2013 65
2014 75
2015 74
2016 86
2017 73
2018 78
2019 74
2020 91
2021 76
2022 80
2023 65
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

1,278 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Skin Squamous Cell Carcinoma"
Page 1
Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.
Que SKT, Zwald FO, Schmults CD. Que SKT, et al. J Am Acad Dermatol. 2018 Feb;78(2):237-247. doi: 10.1016/j.jaad.2017.08.059. J Am Acad Dermatol. 2018. PMID: 29332704 Review.
Cutaneous squamous cell carcinoma (cSCC), a malignant proliferation of cutaneous epithelium, represents 20% to 50% of skin cancers. ...
Cutaneous squamous cell carcinoma (cSCC), a malignant proliferation of cutaneous epithelium, represents 20% to 50% of …
Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Corchado-Cobos R, García-Sancha N, González-Sarmiento R, Pérez-Losada J, Cañueto J. Corchado-Cobos R, et al. Int J Mol Sci. 2020 Apr 22;21(8):2956. doi: 10.3390/ijms21082956. Int J Mol Sci. 2020. PMID: 32331425 Free PMC article. Review.
Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in humans and its incidence continues to rise. Although CSCC usually display a benign clinical behavior, it can be both locally invasive and metastatic. The signaling pathways …
Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in humans and its incidence continues to ri …
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
Migden MR, Rischin D, Schmults CD, Guminski A, Hauschild A, Lewis KD, Chung CH, Hernandez-Aya L, Lim AM, Chang ALS, Rabinowits G, Thai AA, Dunn LA, Hughes BGM, Khushalani NI, Modi B, Schadendorf D, Gao B, Seebach F, Li S, Li J, Mathias M, Booth J, Mohan K, Stankevich E, Babiker HM, Brana I, Gil-Martin M, Homsi J, Johnson ML, Moreno V, Niu J, Owonikoko TK, Papadopoulos KP, Yancopoulos GD, Lowy I, Fury MG. Migden MR, et al. N Engl J Med. 2018 Jul 26;379(4):341-351. doi: 10.1056/NEJMoa1805131. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863979 Free article. Clinical Trial.
In the dose-escalation portion of the phase 1 study of cemiplimab, a deep and durable response was observed in a patient with metastatic cutaneous squamous-cell carcinoma. METHODS: We report the results of the phase 1 study of cemiplimab for expansion …
In the dose-escalation portion of the phase 1 study of cemiplimab, a deep and durable response was observed in a patient with metastatic …
Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA, Ashack KA, Khachemoune A. Burton KA, et al. Am J Clin Dermatol. 2016 Oct;17(5):491-508. doi: 10.1007/s40257-016-0207-3. Am J Clin Dermatol. 2016. PMID: 27358187 Review.
Non-melanoma skin cancer represents one-third of all malignancies and its incidence is expected to rise until the year 2040. Cutaneous squamous cell carcinoma (cSCC) represents 20 % of all non-melanoma skin cancer and is a deadly threat owing to …
Non-melanoma skin cancer represents one-third of all malignancies and its incidence is expected to rise until the year 2040. Cutaneou …
Update of advanced cutaneous squamous cell carcinoma.
de Jong E, Lammerts MUPA, Genders RE, Bouwes Bavinck JN. de Jong E, et al. J Eur Acad Dermatol Venereol. 2022 Jan;36 Suppl 1(Suppl 1):6-10. doi: 10.1111/jdv.17728. J Eur Acad Dermatol Venereol. 2022. PMID: 34855246 Free PMC article. Review.
The incidence of cutaneous squamous cell carcinoma (cSCC) is rapidly increasing. A growing part of this patient group is formed by immunocompromised patients, for example organ-transplant recipients (OTR). ...Anti-PD-1 antibodies show promising results with r …
The incidence of cutaneous squamous cell carcinoma (cSCC) is rapidly increasing. A growing part of this patient group i …
Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends.
Kallini JR, Hamed N, Khachemoune A. Kallini JR, et al. Int J Dermatol. 2015 Feb;54(2):130-40. doi: 10.1111/ijd.12553. Epub 2014 Nov 27. Int J Dermatol. 2015. PMID: 25428226 Review.
Squamous cell carcinoma (SCC) is the second most common non-melanoma skin cancer. ...
Squamous cell carcinoma (SCC) is the second most common non-melanoma skin cancer. ...
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, Bataille V, Bastholt L, Dreno B, Concetta Fargnoli M, Forsea AM, Frenard C, Harwood CA, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NWJ, Malvehy J, Del Marmol V, Middleton MR, Moreno-Ramirez D, Pellecani G, Peris K, Saiag P, van den Beuken-van Everdingen MHJ, Vieira R, Zalaudek I, Eggermont AMM, Grob JJ; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). Stratigos AJ, et al. Eur J Cancer. 2020 Mar;128:83-102. doi: 10.1016/j.ejca.2020.01.008. Epub 2020 Feb 26. Eur J Cancer. 2020. PMID: 32113942 Free article.
In order to update recommendations on treatment, supportive care, education and follow-up of patients with invasive cutaneous squamous cell carcinoma (cSCC), a multidisciplinary panel of experts from the European Dermatology Forum, the European Association of …
In order to update recommendations on treatment, supportive care, education and follow-up of patients with invasive cutaneous squamous …
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R. Vermorken JB, et al. N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656. N Engl J Med. 2008. PMID: 18784101 Free article. Clinical Trial.
BACKGROUND: Cetuximab is effective in platinum-resistant recurrent or metastatic squamous-cell carcinoma of the head and neck. We investigated the efficacy of cetuximab plus platinum-based chemotherapy as first-line treatment in patients with recurrent …
BACKGROUND: Cetuximab is effective in platinum-resistant recurrent or metastatic squamous-cell carcinoma of the …
Guidelines of care for the management of cutaneous squamous cell carcinoma.
Work Group; Invited Reviewers; Kim JYS, Kozlow JH, Mittal B, Moyer J, Olenecki T, Rodgers P. Work Group, et al. J Am Acad Dermatol. 2018 Mar;78(3):560-578. doi: 10.1016/j.jaad.2017.10.007. Epub 2018 Jan 10. J Am Acad Dermatol. 2018. PMID: 29331386 Free PMC article.
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. ...The primary focus of these recommendations is on evaluation and management of primary cSCC and localized disease, but where rele …
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual in …
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, Bataille V, Bastholt L, Dreno B, Fargnoli MC, Forsea AM, Frenard C, Harwood CΑ, Hauschild A, Hoeller C, Kandolf-Sekulovic L, Kaufmann R, Kelleners-Smeets NW, Malvehy J, Del Marmol V, Middleton MR, Moreno-Ramirez D, Pellecani G, Peris K, Saiag P, van den Beuken-van Everdingen MHJ, Vieira R, Zalaudek I, Eggermont AMM, Grob JJ; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). Stratigos AJ, et al. Eur J Cancer. 2020 Mar;128:60-82. doi: 10.1016/j.ejca.2020.01.007. Epub 2020 Feb 26. Eur J Cancer. 2020. PMID: 32113941 Free article.
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. ...Advanced cSCC is classified as locally advanced (lacSCC), and metastatic (mcSCC) includin …
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accountin …
1,278 results